Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 7 | 2022 | 1469 | 1.020 |
Why?
|
| Antigens, Neoplasm | 4 | 2019 | 1993 | 0.860 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2019 | 40 | 0.680 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 2 | 2017 | 168 | 0.570 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 304 | 0.510 |
Why?
|
| T-Lymphocytes | 11 | 2022 | 10194 | 0.500 |
Why?
|
| DNA Transposable Elements | 1 | 2016 | 755 | 0.410 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 940 | 0.380 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2017 | 1626 | 0.380 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 2547 | 0.380 |
Why?
|
| Lymphoma | 1 | 2020 | 1901 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2827 | 0.280 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3878 | 0.220 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5146 | 0.190 |
Why?
|
| Mice, Inbred NOD | 4 | 2019 | 1827 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2020 | 120 | 0.170 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2019 | 85 | 0.170 |
Why?
|
| Neoplasms | 3 | 2019 | 22173 | 0.170 |
Why?
|
| Antigens, CD19 | 2 | 2019 | 424 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 3605 | 0.160 |
Why?
|
| Single-Chain Antibodies | 1 | 2019 | 111 | 0.150 |
Why?
|
| Mice, SCID | 3 | 2019 | 2626 | 0.140 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2019 | 237 | 0.140 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 196 | 0.140 |
Why?
|
| Terminal Repeat Sequences | 1 | 2016 | 70 | 0.130 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 372 | 0.130 |
Why?
|
| Endonucleases | 1 | 2019 | 371 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.130 |
Why?
|
| Glioblastoma | 2 | 2019 | 3483 | 0.120 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.120 |
Why?
|
| Splenic Neoplasms | 1 | 2014 | 94 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2015 | 256 | 0.110 |
Why?
|
| Mice | 8 | 2019 | 81539 | 0.110 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 285 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 670 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2015 | 491 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2014 | 178 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4281 | 0.100 |
Why?
|
| Animals | 10 | 2019 | 168475 | 0.100 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 5485 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1860 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 1896 | 0.090 |
Why?
|
| Cytokines | 2 | 2022 | 7396 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1898 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16990 | 0.070 |
Why?
|
| Protein Binding | 1 | 2019 | 9353 | 0.070 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 3801 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 3847 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5790 | 0.060 |
Why?
|
| Humans | 16 | 2022 | 761596 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9542 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8554 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17635 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4317 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12794 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18255 | 0.040 |
Why?
|
| Acidaminococcus | 1 | 2019 | 9 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2020 | 23447 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2022 | 553 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9032 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6938 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 364 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 126 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 257 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 214 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 30053 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3162 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2022 | 11530 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2014 | 740 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10451 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6131 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3733 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 1218 | 0.020 |
Why?
|
| Transfection | 1 | 2017 | 5774 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2510 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2832 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2457 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29629 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 2665 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 6864 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9490 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 39969 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15936 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64685 | 0.010 |
Why?
|
| Female | 1 | 2019 | 392705 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_